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Background: The aim of this study was to determine the clinical significance of posterior choroidal thickness and
vascular changes in the convalescent stage of Vogt-Koyanagi-Harada disease (VKH). Macular spectral domain optical
coherence tomography (SD-OCT) images of 22 eyes of 13 consecutive patients with VKH at the convalescent stage
were compared to 17 eyes of 9 age/sex/refraction-matched normal subjects. The choriocapillaris layer, medium
choroidal vessels (Sattler's layer), and large choroidal vessels (Haller's layer) were assessed in foveal SD-OCT scans.
The presence and the extent of disruption of outer retinal structures were also noted. Inner and outer choroid
boundaries were manually drawn on horizontal raster SD-OCT scans, and choroidal thickness and volume maps
were generated. Correlation analysis was run to assess the association of the above parameters in the VKH patients
compared to the normal subjects.
Results: In the eyes with convalescent stage of VKH, mean choroidal thickness in the foveal central subfield
(200 ± 60 μm) was lower than in matched controls (288 ± 40 μm) (P < 0.0001). A thinner sub-macular choroid
correlated with a lower visual acuity in uveitis eyes (Pearson correlation, r = −0.5089, P = 0.005). While the
choriocapillaris layer was continuous and intact in all control eyes, various degrees of choriocapillaris loss were
observed in 11 eyes (50%) with VKH (P < 0.0001). In these patients, the presence of outer retinal disruption was
associated with a lower visual acuity (Spearman correlation, P < 0.001).
Conclusions: The choroid is significantly thinner and the choriocapillaris layer is disrupted in the eyes with
convalescent stage of VKH. Evaluation of the choriocapillaris in SD-OCT scans may be a useful surrogate marker for
visual function in the convalescent stage of VKH.
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Vogt-Koyanagi-Harada disease (VKH) is a bilateral pos-
terior uveitis or panuveitis that typically presents with
distinct clinical features based on the duration and stage
of the disease [1,2]. The acute stage of VKH is followed
by the convalescent stage of the disease, and the latter is
characterized by resolution of retinal detachments with
disappearance of cells in the anterior chamber and vitreous
with characteristic sunset glow fundus changes. Usually,* Correspondence: nrao@usc.edu
1Department of Ophthalmology, Keck School of Medicine of the University
of Southern California, Los Angeles, CA 90033, USA
3USC Eye Institute, University of Southern California, 1450 San Pablo Street,
DVRC211, Los Angeles, CA 90033, USA
Full list of author information is available at the end of the article
© 2014 Nazari et al.; licensee Springer. This is a
Attribution License (http://creativecommons.or
in any medium, provided the original work is psuch convalescent stage develops 12 weeks after the onset
of VKH. Histopathologic studies of acute VKH reveal
diffuse, uveal infiltrations of mononuclear inflammatory
cells, primarily lymphocytes, interrupted by focal aggre-
gates of epithelioid histiocytes and multinucleated giant
cells, with sparing of the choriocapillaris from the in-
flammatory infiltration. The convalescent stage of the
disease reveals loss of choroidal melanocytes with focal
infiltration of few lymphocytes [3,4]. The patients with
long-standing duration of the convalescent stage may
show choroidal atrophy and loss of choroidal melanocytes
[3,5,6]. Our knowledge of choroidal vascular changes in
VKH is limited in part due to inherent limitations of im-
aging studies such as angiography to evaluate intervascu-
lar choroidal stromal changes [6].n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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angiography, and histology have been the only modalities
to study choroidal stroma. In recent years, spectral domain
optical coherence tomography (SD-OCT) has been used
to evaluate both the normal choroid and the choroid in
inflammatory and degenerative diseases [7-9]. Previously
unseen details of the choroidal stroma and vasculature,
including the choriocapillaris layer and the diameter
and distribution of medium (Sattler's layer) and large
(Haller's layer) choroidal vessels, are imaged in SD-OCT
scans [10,11]. It is suggested that further insight into chor-
oidal vascular morphology using SD-OCT imaging could
potentially improve diagnosis and management of patients
with ocular disease affecting the choroid [10,11]. A few
attempts have been made to analyze choroidal vessels by
manual and automated segmentation of SD-OCT scans in
macular degeneration and in normal eyes [11-13]. Never-
theless, SD-OCT evaluations of choroidal vasculature in
ocular inflammatory diseases in which the choroid is the
major site of involvement are scarce.
SD-OCT-assisted monitoring of choroidal thickness,
volume, and microstructure is considered helpful in es-
timating the burden of inflammation in the choroid
and predicting the potential for recovery in acute VKH
[14-17]. However, information regarding the SD-OCT
features of the choroid in non-acute-phase VKH is lim-
ited [4,14-18]. Here, we used a qualitative approach to
evaluate sub-foveal choroidal vasculature and choroidal
thickness in SD-OCT scans to determine the clinical signifi-
cance of the choroidal vascular changes and thickness in
VKH during the convalescent stage.
Methods
Subjects
We retrospectively collected data from 26 eyes of 13
consecutive patients with VKH at the convalescent stage
[19] and 17 normal eyes from 9 healthy individuals
who were seen between 2010 and 2012. The normal
controls were from a pool of volunteers with no evidence
of eye disease.
All subjects underwent a complete ophthalmic exam-
ination and SD-OCT imaging. All control subjects had a
best-corrected visual acuity (BCVA) of 20/20 or better
and normal eye examination findings. All consecutive
patients with the diagnosis of VKH based on the revised
diagnostic criteria for VKH [20] were included if they
were followed for at least 3 months after initial presentation
with acute VKH, showed resolution of retinal detachment
and cells in the anterior chamber and vitreous, and dis-
played sunset glow fundus changes [4]. Clinical information
including demographic data, medical and ocular history,
BCVA, slit-lamp biomicroscopy and fundus examination
findings, and treatment details were collected from
the medical records. The study was approved by theInstitutional Review Board of the University of Southern
California and conformed to the tenets set forth in the
Declaration of Helsinki.
Scanning protocol and development of choroidal
thickness and volume maps
The SD-OCT scans were obtained with the Spectralis
HRA+OCT (Heidelberg Engineering, Heidelberg, Germany).
SD-OCT data were exported and imported into Doheny
Image Reading Center OCTgrading software (3D-OCTOR)
as described in detail before [21,22]. The inner and outer
boundaries of the choroid were manually drawn on all
B-scans to allow computation of thickness and volume
values for the entire scanned region. The choroid was
defined as the outer boundary of the retinal pigment
epithelium (RPE)-Bruch's membrane complex to the
inner boundary of the hyperreflective sclera (Figure 1).
All segmentations were performed by two independent,
masked graders. Interobserver variability in choroidal
thickness measurement was compared using Bland-Altman
plots. Reproducibility was also assessed using the intraclass
correlation coefficient.
Choroidal thickness and volume values were reported
using a modified macular Early Treatment Diabetic
Retinopathy Study (ETDRS) grid layout to facilitate ana-
lysis and comparison. ETDRS subfields consist of a central
circle with a diameter of 1,000 μm that is surrounded by
two larger circles, all centered on the fovea. The middle
and outer circles encompass an area with a diameter of
3,000 and 5,000 μm, respectively. The sub-foveal choroid
was defined as the choroid included within the central cir-
cle. The parafoveal choroid was defined as the choroid
contained within the inner circular band with a width of
1,000 μm circling the foveal area. The entire posterior
choroid was defined as the portion of the choroid within
the 5,000-μm-diameter circle centered on the fovea.
Qualitative evaluation of the choroidal vessels and retina
The three histologically defined layers of choroidal vas-
culature, the choriocapillaris, medium choroidal vessels
(Sattler's layer), and large choroidal vessels (Haller's layer),
were individually evaluated for the extent of preservation
or loss using a single horizontal SD-OCT scan passing
through the fovea (Figure 2) [10,12,13,23]. Choroidal
vessel diameters were measured with the caliper tool
within 3D-OCTOR software. A hyporeflective band
approximately 30 μm thick, located immediately adja-
cent to the outer border of the RPE/Bruch's membrane
complex, was considered equivalent to the choriocapil-
laris layer (Figure 1) [10,11]. Even in normal individ-
uals, some focal areas of discontinuity are typically
seen in this hyporeflective band because of the sinus-
oidal and lobular nature of this vascular network, with
intervening intersinusoidal walls and communications
Figure 1 Choroidal thickness maps and spectral domain optical coherence tomography scans. Choroidal thickness maps in a patient with
Vogt-Koyanagi-Harada disease at the convalescent stage (A) and in a normal control (C). Respective spectral domain optical coherence tomography
scans passing through the fovea with marking of choroidal boundaries are presented in panels (B) and (D).
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layer was defined based on the presence of hyperreflective
vessel walls and hyporeflective lumens of 30- to 80-μm
diameters located external to the choriocapillaris layer
(Figure 1) [10,11]. Larger, outer choroidal vessels of
Haller's layer appeared as even larger round structures
with hyperreflective walls and hyporeflective lumens
with diameters greater than 80 μm (Figure 2) [10,11]. The
length of the absent and preserved parts of each layer was
measured using digital calipers within the 3D-OCTORFigure 2 Choroidal vasculature in a normal eye and its enlarged view
domain optical coherence tomography scan (A). Plate (B) demonstrates an
The choriocapillaris layer appears as a hyporeflective band just next to the
Haller's layer (large choroidal vessels) is usually seen as reflectance-free rou
choroid (white arrows). Sattler's layer (medium choroidal vessels) is located
appears more reflective, probably because of the presence of more compagrading software and expressed as the percentage of the
total length of the scan. Because areas of discontinuity
in the choriocapillaris layer are expected in the normal
choroid for the reasons described above, we conserva-
tively did not deem definite loss to be present unless at
least 25% of the band was absent. This choice of 25%
was based on previous inspection of normal controls in
prior studies (unpublished), where the hyporeflective
choriocapillaris band was discontinuous for up to 25% of
the scan length in some eyes. For categorical classification. Choroidal vasculature in a normal eye as revealed in a spectral
enlarged view of the area marked by a dashed rectangle in plate (A).
outer border of the retinal pigment epithelium (red arrowheads).
nd structures with a large diameter at the outermost parts of the
between the choriocapillaris and Haller's layer (white braces) and
ct vessel walls and denser interstitial tissue.
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band for >75% of the horizontal foveal-centered B-scan
was deemed ‘intact,’ 74% to 50% was defined as ‘mild loss,’
49% to 25% as ‘moderate loss, and <25% as ‘severe loss’
(Figure 3). For simplicity and consistency, the same categor-
ical system and definitions were used to grade medium
choroidal vessel loss. Since large choroidal layer vessels are
not continuously or evenly distributed across the entire
length of an SD-OCT B-scan of the normal eye [10,11], any
visible large choroidal vessel was graded as evidence of the
presence of Haller's layer, and the absence of these vessels
in the horizontal foveal scan was considered to be evidence
of loss of Haller's layer (Figure 4).
Structural changes of the retina and RPE, including
cystoid macular edema, full-thickness and lamellar
macular hole, external limiting membrane (ELM) dis-
ruption, ellipsoid zone (EZ) disruption, RPE hyperpla-
sia/hypertrophy, presence of an epiretinal membrane
(ERM), and evidence of RPE atrophy, were also graded
on the sub-foveal SD-OCT scans. The extent of ELM
and EZ disruptions and RPE atrophy was graded based
on a grading scheme of 0 to 3, with grade 0 defined as no
disruption/atrophy, grade 1 defined as loss of 1% to
33% of the band, grade 2 defined as 34% to 66% loss,
and grade 3 indicating disruption or loss of these
bands in more than 66% of the length of the horizon-
tal sub-foveal SD-OCT scan. Any disruption/atrophy
within the central 1,000 μm of the scan (foveal center
area) was considered grade 3.Figure 3 A representative patient with convalescent stage of Vogt-Ko
examination. (A) Foveal area spectral domain optical coherence tomograph
marked by a dashed rectangle is enlarged in plate (B) to show the areas w
the choriocapillaris (between the brackets). Medium and large choroidal ve
same patient.Snellen visual acuity (VA) was converted to the logarithm
of the minimal angle of resolution (logMAR) and presented
as mean ± standard deviation (SD). Continuous data were
compared using Student's t test. The preservation or
disruption of three layers of choroidal vessels in uveitis
and control eyes was compared using the chi-square
test. The association of choroidal thickness and volume
data with VA was analyzed with Spearman correlation
analysis. Choriocapillaris loss grading and SD-OCT
features and VA were correlated using Pearson correl-
ation coefficients. The accepted level of significance was
considered to be P < 0.05.
Results
Twenty-two eyes of 13 patients (four males and nine
females) with convalescent stage of VKH [19] and 17
eyes of 9 normal controls (three males and six females) were
included. Mean ± SD age of the patient group (43 ± 11 years,
range 26 to 65 years) did not differ significantly from
that of the controls (35.6 ± 3.7 years, range 32 to 40 years,
P = 0.07). Mean spherical equivalent of the patients with
available refraction data (8 of 22) was −0.39 D, and that
of the controls (all eyes had refraction data) was −2.10
D (P = 0.07). Visual acuity in control eyes was better
than visual acuity in the eyes with VKH (mean LogMAR
VA 0.17 ± 0.23, range 0 to 0.7, P < 0.0001). Mean VKH
duration was 110 ± 109 months (median 69 months,
range 9 to 360 months). In four patients, the OCT
image obtained for one eye only was included. Theyanagi-Harada disease. Visual acuity was 20/20 at the time of
y scan demonstrates focal loss of the choriocapillaris layer. The area
ith preserved choriocapillaris (red brackets) and those with focal loss of
ssels are preserved. (C) Wide-field color fundus picture from the
Figure 4 Extensive choriocapillaris loss in a patient with long-standing convalescent stage of Vogt-Koyanagi-Harada disease with
20/100 vision. Fundus examination demonstrates a prominent sunset glow fundus appearance with large patches of choroidal and retinal
pigment epithelium atrophy (B). Spectral domain optical coherence tomography scan showed extensive loss of the choriocapillaris and thinning
of the retina (A). The retinal pigment epithelium is atrophic demonstrating significant backscattering from the choroid and sclera (A). The dashed
area is magnified in plate (C) to show the details.
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three reasons: one eye was phthisical, allowing no
view of the fundus; one eye had a history of pars
plana vitrectomy for macular hole; and the SD-OCT
image quality in two eyes was too poor to allow
confident segmentation of the choroidal boundaries. One
control eye was also excluded from the analysis because
of poor scan quality. Of the 13 patients with VKH, six
were on systemic immunomodulatory treatment at the
time of data collection.
Average choroidal thickness at the fovea was 200
±60 μm (median 202 μm, range 54 to 305 μm) in the
VKH group and 288 ± 40 μm (median 286 μm, range
229 to 350 μm) in the control group (P < 0.0001).
Choroidal thickness and volume in the foveal plus
parafoveal zones and in the entire macula were also
significantly less compared to normal controls
(Table 1).
Sub-foveal choroidal thickness negatively corre-
lated with VA (r = −0.5089, P = 0.005, Figure 5).
Choroidal thickness in the parafoveal area and in
the entire macula also negatively correlated with VA
(r = −0.5358, P = 0.003 and r = −0.5413, P = 0.003, re-
spectively). Choroidal thickness and volume in the
fovea, the parafovea, and the entire macula did
not correlate with the duration of disease. Longer
disease duration, however, did show a trend for
association with lower VA, albeit not statistically sig-
nificant (r = 0.2869, P = 0.07).
Choroidal structures representing the choriocapil-
laris, medium choroidal vessels, and large choroidal
vessels were graded to be intact in all controls. In pa-
tients with convalescent VKH, 11 eyes (50%) were
found to have an intact choriocapillaris (i.e., preserva-
tion of the choriocapillaris-equivalent hyporeflectiveband in more than 75% of the length of the horizon-
tal foveal SD-OCT scan). Two eyes had mild loss
(26% to 50% loss), four eyes had moderate loss (51%
to 75% loss), and five eyes had severe loss of the
choriocapillaris (>75% loss) (Figure 4). The extent of
choriocapillaris loss correlated with VA (Pearson cor-
relation, r = 0.6868, P < 0.00001) but not with disease
duration (Pearson correlation, r = 0.0324, P = 0.88).
Medium choroidal vessels were present in all eyes;
but the larger choroidal vessels could not be identi-
fied in five eyes (22.7%). These five eyes also had the
most severe damage (complete loss) to the chorioca-
pillaris layer (Figure 4). The severity of choriocapil-
laris loss correlated inversely with choroidal thickness
at the fovea (Pearson correlation analysis, r = −0.4445,
P = 0.04).
The presence of significant (grade 3) photoreceptor
EZ disruption (two eyes), ELM disruption (three eyes), and
RPE atrophy (two eyes) in horizontal foveal-centered
SD-OCT scans correlated with lower VA (Spearman
correlation coefficients = 0.65588, 0.77638, 0.65891,
respectively, P < 0.001). The presence of ERM at the
fovea also correlated with lower VA (Spearman correl-
ation coefficient = 0.41177, P = 0.02). The sub-foveal
choroid was significantly thinner in the eyes with retinal/
RPE changes (170 ± 62 μm, range 54 to 245 μm) com-
pared to the eyes with normal retina and RPE at the fovea
(222 ± 51 μm, range 121 to 305 μm, P = 0.05). The choice
of medications used for patients was not associated with
VA or any other study variable.
Bland-Altman plots of the mean choroidal thickness
in various ETDRS subfields showed a significant
agreement for the measurements by two independent
graders (Figure 6). The interclass correlation coeffi-
cient for sub-foveal and entire macular choroidal
Table 1 Choroidal vasculature changes and choroidal thickness and volume values in convalescent VKH patients
compared to controls
Patients Controls P value
No. 13 (22 eyes) No. 9 (17 eyes)
Choroidal thickness, mean ± SD (range), μm
Fovea 200 ± 60 (54 to 305) 288 ± 40 (229 to 350) <0.0001 (Student's t test)
Parafovea 209 ± 61 (46 to 3.5) 278 ± 36 (209 to 333) <0.0001 (Student's t test)
Entire macula 198 ± 58 (44 to 282) 268 ± 32 (202 to 318) <0.0001 (Student's t test)
Choroidal volume, mean ± SD (range), μm
Fovea 0.99 ± 0.31 (0.21 to 1.49) 1.49 ± 0.21 (1.17 to 1.82) <0.000 (Student's t test)
Parafovea 1.28 ± 0.37 (0.29 to 1.9) 1.75 ± 0.23 (1.32 to 2.11) <0.0001 (Student's t test)
Entire macula 5.33 ± 1.60 (1.01 to 7.33) 7.51 ± 0.93 (5.6 to 9.02) <0.0001 (Student's t test)
Preservation of choroidal vessel layers
Choriocapillaris-equivalent layer 11/22 (50%) 17/17 (100%) <0.000 (chi-square)
Medium choroidal vessels 22/22 (100%) 17/17 (100%) 1
Large choroidal vessels 17/22 (77%) 17/17 (100%) <0.000 (chi-square)
Choroidal thickness and volume values in the eyes with convalescent Vogt-Koyanagi-Harada disease were significantly lower than those in controls. Also, the
choriocapillaris and large choroidal vessels were significantly lost in convalescent Vogt-Koyanagi-Harada disease.
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interval (CI) 0.9483 to 0.9923) and 0.9767 (95% CI
0.9406 to 0.9909), respectively.Discussion
In the current study, quantitative mapping of choroidal
thickness and volume and qualitative analysis of choroidal
vascular integrity showed loss of choroidal tissue including
the choriocapillaris layer in the convalescent stage of VKH.
Additionally, loss of the choriocapillaris and the thin-
ning of the choroid in the sub-macula area correlatedFigure 5 Sub-foveal choroidal thickness in correlation to the visual acwith increased duration of the disease, lower VA, and
the presence of structural changes in the retina.
Normal sub-foveal choroidal thickness measured by
SD-OCT ranges from 260 to 287 μm and varies by age, re-
fractive error, and ethnicity [24-26]. Choroidal thickness
varies based on the nature of posterior segment pathology
as well. For instance, choroidal thickness increases in
hyperopia [24], acute VKH [14,15,18], central serous
chorioretinopathy [27,28], and polypoid choroidal vas-
culopathy [29,30]. On the other hand, loss of choroidal
mass has been seen in high myopia [24], age-related
macular degeneration [29], macular hole [30],uity (r = −0.5089, P = 0.005).
Figure 6 Bland-Altman plots demonstrating the interobserver agreement of sub-foveal (A) and entire macular (B) choroidal
thickness measurements.
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mation [32]. Decreased choroidal thickness and vol-
ume in chronic VKH is in contrast to what is observed
in the acute phase of the disease [14,18,33]. Similarly,
Nakai et al. have recently shown that sub-foveal chor-
oidal thickness in Japanese patients with chronic VKH
is significantly thinner than that in normal controls
[18]. But Nakai and colleagues measured foveal chor-
oidal thickness and did not map choroidal thickness in
the entire posterior pole, as in our study [18]. We agree
with Nakai et al. that choroidal thinning is most likely
due to inflammatory damage to the choroidal stroma
and vasculature, with the eventual resultant atrophy
and fibrosis; however, this can be verified if OCT scans
are correlated to the findings of simultaneously acquired
indocyanine green angiography. Seeing decreased hyperre-
flective foci in enhanced-depth OCT images of the pa-
tients with chronic VKH, Fong et al. speculated that
stromal scarring and the resulting shrinkage and dropout
of small vessels in the choroid are the reasons for chor-
oidal thinning in the convalescent stage of VKH [14]. Our
observations on the loss of the choriocapillaris layer in the
convalescent phase of VKH would appear to be consistent
with the hypothesis of Fong et al. about the mechanism of
choroidal thinning in chronic VKH [14].
Choroidal vessels are typically classified into three
layers based on their diameter and permeability charac-
teristics [26]. The choriocapillaris is particularly notable
for supporting the physiologic needs of photoreceptors.
Morphometric analysis of the choriocapillaris in histo-
logic sections shows that this structure typically has a
diameter of 6.5 to 9.8 μm [34]. SD-OCT studies estimate
the choriocapillaris thickness to be somewhat thicker.
There are several potential reasons for this apparent
discrepancy. First, assessing the thickness of dynamic
vascular structures by histology may be inaccurate. These
vascular structures may collapse postmortem, leading toan underestimate compared to in vivo thickness. Second,
optical imaging methods provide only an indirect repre-
sentation of a particular structure. We know that the
hyporeflective band external to the RPE/Bruch's mem-
brane complex is in the vicinity of the choriocapillaris;
however, the presence of this band on the scan is due to
its optical properties, and this may not perfectly match
the physical structure of the tissues or interfaces of inter-
est. Third, the thickness of the choriocapillaris may be at
the resolution limit of our SD-OCT devices. This may
limit the ability to more precisely measure the true thick-
ness of these structures. Despite these limitations, given
the crucial role of the choriocapillaris in providing nour-
ishment to the photoreceptors and the RPE and the in-
volvement of the choroid by many ocular inflammatory
diseases, evaluation of the choroid may be useful for pre-
dicting visual outcomes in eyes with uveitis. In our series,
the choriocapillaris layer appeared to show varying degrees
of loss in 50% of the eyes with VKH during the convalescent
stage. Additionally, the extent of choriocapillaris loss
correlated with lower VA (Pearson correlation, r= 0.6868,
P < 0.00001). In eyes with complete loss of the choriocapil-
laris layer, the outer retina was also atrophic, resulting in
lower VA. These findings would appear consistent with his-
topathologic reports from advanced and long-standing cases
of chronic VKH [6]. Thus, evaluating the status of the chor-
iocapillaris with foveal SD-OCT scans in eyes with VKH may
be useful for gauging the functional potential of the eye.
Choroidal thickness and volume appear to be reduced in
long-standing cases of VKH, but these measurements cannot
always be performed in the clinic. Assessment of the integrity
of the choriocapillaris layer may prove to be an easier and
more practical clinical tool for predicting the visual prognosis
of patients withVKH during the convalescent stage.
Choroidal thinning and loss of the choriocapillaris
were associated with retinal structural changes in the
fovea and lower VA. Outer retinal damage is frequently
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In our series of VKH patients at the convalescent stage,
significant photoreceptor EZ and ELM disruptions,
ERM, and severe RPE alteration were observed in a
small proportion of patients (9% to 14% of eyes); how-
ever, the presence of such retinal and RPE structural
abnormalities correlated with lower VA and thinner
choroid. Inflammatory damage is considered the under-
lying cause for loss of the choroidal vasculature and outer
retinal damage in the setting of chronic VKH. Decreased
choriocapillaris density in the fovea may compromise the
overlying retina and visual function. Choriocapillaris drop-
out is proposed to play a major role in the pathogenesis of
photoreceptor damage in age-related macular degener-
ation. In a mouse model of progressive choriocapillaris
loss, choriocapillaris atrophy was accompanied by exten-
sive retinal atrophy and outer retinal loss [35]. A similar
process may play a role in retinal damage and decreased
vision in long-standing VKH cases with damage to the
choriocapillaris. Further longitudinal morphometric
analysis of the choroidal structure may help clarify the
process leading to choroidal thinning in long-standing
inflammatory choroiditis.
Our study has several limitations which must be consid-
ered when assessing the results. First, it is a retrospective
review and thus potentially subject to confounders such
as selection bias. In addition, the population of patients
was non-homogenous with patients treated by various
agents with potentially varying degrees of success. Sec-
ond, the overall sample size is small, thus reducing the
power to detect smaller differences between the various
groups/features under study. However, assembling a
large cohort of patients with chronic VKH is a difficult
task. Third, although we made an effort to match our
cases with controls of a similar younger age, the control
group was still slightly younger (not statistically signifi-
cant), and the choroid is generally thicker in younger
patients. On the other hand, the control group was
slightly more myopic, and the choroid is generally thin-
ner in myopes. Overall, we believe that these two poten-
tial imbalances may have canceled one another out.
Fourth, our grading definitions (such as the percentage
of discontinuity of the layer) were somewhat arbitrary.
On the other hand, excellent grading reproducibility
was achieved using these definitions. However, correlat-
ing SD-OCT images to findings of indocyanine green
angiography could provide a better overall evaluation of
the choroid in uveitis. Despite the limitations, our study
has several strengths, including the use of trained expe-
rienced graders and a standardized grading protocol
with documented reproducibility. Also, in VKH, future
studies during the long course of disease should include
linear evaluation of the choroidal stroma and choroidal
vascular changes.Conclusions
In summary, choroidal atrophy takes place in eyes with
long-standing VKH. The atrophy correlates with uveitis
duration, suggesting that patients with a longer duration
of disease tend to have thinner choroids. Such loss of
choroidal thickness and volume appears to be, in part, due
to loss of choroidal vasculature, including the choriocapil-
laris layer. Such changes are associated with atrophy of the
overlying retina and RPE and lower visual acuity. Also, sub-
foveal choroidal thickness, but not choroidal volume values,
correlates with visual acuity. Thus, evaluating sub-foveal
choroidal thickness and the changes in the choriocapillaris
layer may be a useful approach in evaluation of visual out-
come in patients with convalescent stage of VKH.
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